“What’s the worst that could happen?” – Jeff
Hey there carnivores,
Markets were mixed yesterday as investors waited for stimulus news.
And today we’re talking FDA approvals.
Jeff & Jason
We got next. – the FDA waiting to approve Pfizer’s vaccine
It appears that FDA approval of Pfizer’s ‘rona vaccine is imminent after an advisory panel from the Food and Drug Administration recommended broad distribution of the drug to people who are at least 16 years old. Don’t worry, 15-year-olds, I’m sure they have Fortnite in the ICU.
The move comes a day after the drug was approved by our neighbors to the north, and a week after this cute old lady was the first in the world to take the Pfizer shot to the arm (outside of clinical trials).
Stock futures remained flat as investors appear to be more interested in the unresolved stimulus deal. But PFE and BNTX rose 2.4% and 5.4%, respectively after hours.
Just the beginning
All parties involved agree that the vaccine has reached a level of efficacy (95%) that will help earth’s current “predicament,” but long term effects are still TBD. One area of focus is figuring out if the vaccine has a benefit for children under 16. Your parents definitely don’t love you if they let you be part of that test.
The FDA will continue to monitor results to make sure that the benefits continue to outweigh the risks of the vaccine. Now the trick is just getting people to actually take it…
The bottom line…
Make sure to order those Crocs now if you want them in time for Christmas. Both UPS and FedEx have said that they are going to give priority to shipments of the vaccine this holiday season.
The precious cargo will also have GPS tracking so recipients can be disappointed in real time as they realize their ‘vid vaxx dose will arrive before their PS5.
Ah sh*t, here we go again
America’s unemployment numbers are on the rise again, with the number of first time unemployment benefit claims clocking in at 950k. This is the highest level since the middle of September, the third increase in four weeks, and breaks the country’s seven-week streak of initial jobless claims under 800k. Don’t call it a comeback.
Continued jobless claims rose to 5.8M, which was the first increase week over week since the end of August. With so many people out of work, one has to wonder: isn’t there a body of elected officials that could pass a bill to help those in need of assistance?
“Oh boy, haha”
Disney had its investor day yesterday, and let’s just say that the only better presentation was done by Prestige Worldwide.
Disney reported that its Disney+ streaming service has 86.8M subscribers, up from 73M at the end of fiscal Q4. Mickey and the gang announced that 50 more movies and shows will be added, including 10 Marvel series, 10 Star Wars series, various Disney shows, and the Mighty Ducks *hears “quack, quack, quack…” in the distance*.
Oh yeah, and the streaming service’s price will rise $1, from $6.99 to $7.99 per month.
Disney’s stock reached an all time high on the news, having closed at $154.69 on the day, and rose almost 4% afterhours.
“Are you dropping tracking cookies without consent?…
… because damn, you are fined.” – France’s data protection agency, probably.
France’s data protection agency will fine Google and Amazon for, you guessed it, dropping tracking cookies without a user’s consent. The practice flies in the face of France’s Data Protection Act.
Google was hit with three violations, and was fined $120M. Amazon, with two violations, was fined $42M.
These are my stretchy pants
Lululemon reported Q3 earnings yesterday, and it turns out Jim Gaffigan was right: athleisure is great to wear for lounging around in the house.
Net revenue rose 22% from the same period last year to $1.1B, and same store sales rose 18%. And while 97% of its locations are open, the company expects that productivity at those stores will be roughly 70% below what it was this time last year. Ya know, ‘rona and whatnot.
Q4 is trending positive for the company as revenue growth is projected in the teens and sales after Thanksgiving were at “record-breaking levels”.
*Results presented are not typical and may vary from person to person. Please see our full disclaimer here: ragingbull.com/disclaimer